Fig. 1: Summary of the number of cervical cancer cases, cervical cancer deaths, pre-cancer treatments, additional pre-term delivery events, NNTs and NNSs over the lifetime of a cohort of 100,000 women living with HIV.
From: Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV
The cells are colored to provide an overall impression of strategies that are performing well: best-performing strategies in a column are colored green (best—largest cancer incidence/mortality reduction or the lowest number of pre-cancer treatments, NNTs or NNSs), followed by teal, yellow and then red for the worst-performing strategies. The range for the color coding for each column is shown in Extended Data Fig. 1. bNNS to avert a cervical cancer death includes primary and follow-up testing. yrly, yearly; yrs, years; NNS, number needed to screen.
